|
Glycine-d5
|
甘氨酸D5
|
4896-77-9
|
|
BAY32-5915
|
8-羥基喹啉-2-羧酸
|
1571-30-8
|
|
Lanicemine dihydrochloride
|
ARL15896; ARL 15896; LANICEMINE HYDROCHLORIDE; AR-R15896AR
|
153322-06-6
|
|
AX-024
|
AX-024 HCL
|
1370544-73-2
|
|
L-Glutamic acid-d5
|
氘代L-谷氨酸
|
2784-50-1
|
|
Baloxavir
|
巴洛沙韋
|
1985605-59-1
|
|
Cridanimod
|
吖啶酮乙酸
|
38609-97-1
|
|
IMD 0354
|
N-[3,5-雙(三氟甲基)苯基]-5-氯-2-羥基苯甲酰胺
|
978-62-1
|
|
BZAD-01
|
BZAD01
|
305339-41-7
|
|
MBX2329
|
1-(2-(2-乙基苯氧基)乙基)氮雜環(huán)庚烷鹽酸鹽
|
1438272-42-4
|
|
Molnupiravir
|
莫那比拉韋
|
2492423-29-5
|
|
BI605906
|
化合物 T14567
|
960293-88-3
|
|
Rimantadine Hydrochloride
|
鹽酸金剛乙胺
|
1501-84-4
|
|
Rislenemdaz
|
化合物 T12733
|
808732-98-1
|
|
Decanoic acid-d3
|
10,10,10-氘代癸酸
|
102611-15-4
|
|
Abrocitinib
|
PF-04965842(阿布羅替尼)
|
1622902-68-4
|
|
JNJ-61432059
|
JNJ-61432059
|
2035814-50-5
|
|
AEBSF hydrochloride
|
4-(2-氨乙基)苯磺酰氟鹽酸鹽
|
30827-99-7
|
|
AMPA receptor modulator-3
|
化合物 T27951
|
211311-39-6
|
|
(-)-JNJ-A07
|
化合物 (-)-JNJ-A07
|
2135640-92-3
|
|
Omberacetam
|
N-(1-(苯基乙酰基)-L-脯氨酰)甘氨酸乙酯
|
157115-85-0
|
|
MRT67307
|
N-[3-[[5-環(huán)丙基-2-[[3-(4-嗎啉基甲基)苯基]氨基]-4-嘧啶基]氨基]丙基]環(huán)丁烷甲酰胺
|
1190378-57-4
|
|
NVP-ADW742
|
5-(3-芐氧基苯基)-7-[反式-3-[(吡咯烷-1-基)甲基]環(huán)丁基]-7H-吡咯并[2,3-D]嘧啶-4-胺
|
475488-23-4
|
|
Fanapanel hydrate
|
1255517-78-2
|
1255517-78-2
|
|
UBP608
|
6-溴香豆素-3-甲酸
|
2199-87-3
|
|
Neuraminidase-IN-1
|
化合物 COMPOUND Y-1
|
2379438-80-7
|
|
GSK2245035
|
GSK2245035
|
1207629-49-9
|
|
Golidocitinib
|
AZD4205
|
2091134-68-6
|
|
Rilmenidine Phosphate
|
磷酸利美尼定
|
85409-38-7
|
|
Delgocitinib
|
迪高替尼
|
1263774-59-9
|
|
JNJ4796
|
JNJ4796
|
2241664-16-2
|
|
6-Azathymine
|
6-氮雜胸腺嘧啶
|
932-53-6
|
|
Zapnometinib
|
2-(2-CHLORO-4-IODOPHENYLAMINO)-3,4-DIFLUOROBENZOIC ACID
|
303175-44-2
|
|
Bupivacaine hydrochloride
|
BUPIVACAINE HYDROCHLORIDE
|
18010-40-7
|
|
Farampator
|
CX691
|
211735-76-1
|
|
Quinolinic acid-d3
|
2,3-Pyridinedicarboxylic Acid-d3
|
138946-42-6
|
|
Radiprodil
|
RADIPRODIL
|
496054-87-6
|
|
CX 717
|
苯并[C][1,2,5]惡二唑-5-基(嗎啉)甲酮
|
867276-98-0
|
|
ZL006
|
化合物ZL006
|
1181226-02-7
|
|
N-Glycolylneuraminic acid
|
N-羥乙酰神經(jīng)氨酸
|
1113-83-3
|
|
Trimethobenzamide hydrochloride
|
鹽酸三甲氧苯酰胺
|
554-92-7
|
|
Zelquistinel
|
AGN-241751; GATE-251
|
2151842-64-5
|
|
CX614
|
2,3,6A,7,8,9-六氫-11H-1,4-二惡烷并[2,3-G]吡咯并[2,1-B][1,3]苯并惡嗪-11-酮
|
191744-13-5
|
|
L-Glutamic acid-1-13C
|
L-谷氨酸-2-13C
|
81201-99-2
|
|
Mephenesin
|
甲酚甘油醚
|
59-47-2
|
|
GSK 650394
|
2-環(huán)戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸
|
890842-28-1
|
|
LY450108
|
N-[4-[(1R)-1-甲基-2-[[異丙基磺?；鵠氨基]乙基]苯基]-3,5-二氟苯基甲酰胺
|
376594-67-1
|
|
Fedratinib hydrochloride hydrate
|
TG-101348
|
1374744-69-0
|
|
Tat-NR2B9c TFA
|
TAT-NR2B9C TFA
|
1834571-04-8
|
|
BAY-985
|
BAY-985
|
2409479-29-2
|
|
Procyclidine hydrochloride
|
丙環(huán)定鹽酸鹽
|
1508-76-5
|
|
IDO inhibitor 1
|
4-[[2-[(氨基磺?；?氨基]乙基]氨基]-N'-(3-溴-4-氟苯基)-N-羥基-1,2,5-惡二唑-3-甲脒
|
1204669-37-3
|
|
Mizoribine
|
咪唑立賓
|
50924-49-7
|
|
TBK1/IKKε-IN-4
|
TBK1/IKKΕ-IN-4
|
1381930-17-1
|
|
Robatumumab
|
ROBATUMUMAB ( 羅妥木單抗 )
|
934235-44-6
|
|
L-Phenylalanine-d8
|
氘代L-苯丙氨酸
|
17942-32-4
|
|
Laninamivir
|
拉尼米韋
|
203120-17-6
|
|
Nelonemdaz
|
640290-67-1
|
640290-67-1
|
|
IMD-0560
|
化合物IMD-0560
|
439144-66-8
|
|
Interferon receptor inducer-1
|
INTERFERON RECEPTOR AGONIST
|
2215120-36-6
|
|
TAT-GluA2 3Y
|
H-TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG-TYR-LYS-GLU-GLY-TYR-ASN-VAL-TYR-GLY-OH
|
1404188-93-7
|
|
Teprotumumab
|
TEPROTUMUMAB ( 替妥木單抗 )
|
1036734-93-6
|
|
Moxonidine
|
莫索尼啶
|
75438-57-2
|
|
Indirubin Derivative E804
|
Indirubin Derivative E804
|
854171-35-0
|
|
Tulrampator
|
1038984-31-4
|
1038984-31-4
|
|
TBK1/IKKε-IN-5
|
Benzonitrile, 5-[4-[[4-[4-(3-oxetanyl)-1-piperazinyl]phenyl]amino]-1,3,5-triazin-2-yl]-2-[(tetrahydro-2H-pyran-4-yl)oxy]-
|
1893397-65-3
|
|
I-OMe-Tyrphostin AG 538
|
I-OME-AG 538
|
1094048-77-7
|
|
AMPA receptor modulator-2
|
AMPA RECEPTOR MODULATOR-2
|
2034181-36-5
|
|
GSK1904529A
|
N-(2,6-二氟苯基)-5-[3-[2-[[5-乙基-2-甲氧基-4-[4-[4-(甲基磺?；?-1-哌嗪基]-1-哌啶基]苯基]氨基]-4-嘧啶基]咪唑并[1,2-A]吡啶-2-基]-2-甲氧基苯甲酰胺
|
1089283-49-7
|
|
Sunifiram
|
桑尼非拉姆
|
314728-85-3
|
|
ML 120B dihydrochloride(free base)
|
N-(6-氯-7-甲氧基-9H-吡啶并[3,4-B]吲哚-8-基)-2-甲基-3-吡啶甲酰胺
|
783348-36-7
|
|
ABMA
|
N-(5-bromo-2-methoxybenzyl)tricyclo[3.3.1.1~3,7~]decan-1-amine
|
332108-65-3
|
|
GNE 5729
|
GNE 5729
|
2026635-66-3
|
|
LY3130481
|
LY3130481
|
1610802-47-5
|
|
GSK8612
|
GSK8612
|
2361659-62-1
|
|
CBS1117
|
化合物CBS1117
|
959245-08-0
|
|
PS-1145
|
PS-1145
|
431898-65-6
|
|
MLN120B dihydrochloride
|
MLN120B DIHYDROCHLORIDE
|
1782573-78-7
|
|
BMS345541 hydrochloride
|
N-(1,8-二甲基咪唑并[1,2-A]喹喔啉-4-基)-1,2-乙二胺鹽酸鹽
|
547757-23-3
|
|
Pimodivir
|
VX-787
|
1629869-44-8
|
|
Glycine-1-13C
|
甘氨酸-1-13C
|
20110-59-2
|
|
Sepimostat
|
司匹司他
|
103926-64-3
|
|
MDL 105519
|
3-[(1E)-2-羧基-2-苯乙烯基]-4,6-二氯-1H-吲哚-2-羧酸
|
161230-88-2
|
|
S119-8
|
化合物S119-8
|
443639-96-1
|
|
Ketotifen-d3 (fumarate)
|
YNQQEYBLVYAWNX-PCUGBSCUSA-N
|
1795138-23-6
|
|
L-Phenylalanine-d2
|
L-苯丙氨酸-Β,Β-D2
|
221346-31-2
|
|
Monalizumab
|
莫那利珠單抗
|
1228763-95-8
|
|
IGF-I (24-41)
|
TYR-PHE-ASN-LYS-PRO-THR-GLY-TYR-GLY-SER-SER-SER-ARG-ARG-ALA-PRO-GLN-THR
|
135861-49-3
|
|
(S)-Willardiine
|
尿嘧啶基丙氨酸
|
21416-43-3
|
|
TAK-653
|
9-(4-(環(huán)己氧基)苯基)-7-甲基-3,4-二氫吡嗪[2,1-C][1,2,4]噻二嗪-2,2-二氧化物
|
1358751-06-0
|
|
PF-06263276
|
PF-06263276 (PF 6263276)
|
1421502-62-6
|
|
Pesampator
|
化合物 EOS-62062
|
1258963-59-5
|
|
Budipine
|
叔丁哌苯
|
57982-78-2
|
|
Gusacitinib
|
GUSACITINIB
|
1425381-60-7
|
|
Traxoprodil
|
曲索羅地
|
134234-12-1
|
|
Bupivacaine
|
布比卡因
|
38396-39-3
|
|
GNE-9278
|
化合物 GNE-9278
|
2315311-83-0
|
|
Naspm trihydrochloride
|
N-[3-[[4-[(3-氨基丙基)氨基]丁基]氨基]丙基]-1-萘乙酰胺三鹽酸鹽
|
1049731-36-3
|
|
IFN alpha-IFNAR-IN-1 hydrochloride
|
IFN ALPHA-IFNAR-IN-1鹽酸鹽
|
2070014-98-9
|
|
2,3-Dehydro-2-deoxy-N-acetylneuraminic acid
|
N-乙酰-2,3-二脫氫-2-脫氧神經(jīng)氨酸
|
24967-27-9
|